Cutler Group LP Concert Pharmaceuticals, Inc. Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 09, 2019	SELL	$9.44 - $13.12 $1,888 - $2,624	-200 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$12.07 - $17.54 $3,621 - $5,262	-300 Reduced 60.0%	200 $2,000
Q4 2018 Feb 05, 2019	SELL	$11.25 - $16.17 $13,196 - $18,967	-1,173 Reduced 70.11%	500 $6,000
Q3 2017 Oct 17, 2017	BUY	$13.91 - $15.31 $23,271 - $25,613	1,673	1,673 $24,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.